| |
| |
|
| Insider
Information: |
Sharp Philip A |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
738,118 |
|
|
Indirect Shares
|
440,231 |
|
|
| Direct
Value |
$109,729,776 |
|
|
|
Indirect Value
|
$40,323,306 |
|
|
| Total
Shares |
1,178,349 |
|
|
| Total
Value |
$150,053,081 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Director |
2009-06-03 |
470,278 |
2003-11-12 |
0 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2024-02-29 |
0 |
2024-02-29 |
266,899 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2016-07-06 |
146,666 |
2016-07-06 |
40,000 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2023-05-22 |
121,174 |
2023-05-22 |
133,332 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
86 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2003-11-12 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
818,800 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2004-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
233,333 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2004-05-27 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
221,052 |
|
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2019-10-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,480 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2004-12-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
163 |
421,633 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2004-07-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
335 |
477,665 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2007-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
463,683 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2008-07-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,050 |
468,033 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2009-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,245 |
470,278 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2007-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
465,983 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2021-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,374 |
108,742 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2013-01-22 |
4 |
B |
$20.13 |
$99,986 |
D/D |
4,967 |
14,269 |
2.39 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2023-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,027 |
121,174 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2022-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,405 |
115,147 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2008-04-08 |
4 |
AS |
$64.81 |
$486,470 |
D/D |
(7,500) |
465,983 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2012-02-21 |
4 |
B |
$10.75 |
$99,997 |
D/D |
9,302 |
9,302 |
2.39 |
- |
|
| BIIB |
Biogen Idec Inc |
Director |
– • – |
2004-12-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
14,234 |
421,796 |
|
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2017-01-18 |
4 |
AS |
$37.57 |
$567,456 |
D/D |
(15,000) |
140,795 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2017-01-18 |
4 |
OE |
$15.91 |
$238,650 |
D/D |
15,000 |
155,795 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2017-01-25 |
4 |
AS |
$37.95 |
$569,250 |
D/D |
(15,000) |
140,795 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2017-01-25 |
4 |
OE |
$31.39 |
$470,850 |
D/D |
15,000 |
155,795 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2018-03-09 |
4 |
OE |
$27.28 |
$409,200 |
D/D |
15,000 |
155,795 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2018-03-09 |
4 |
AS |
$129.00 |
$1,935,000 |
D/D |
(15,000) |
140,795 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2018-03-13 |
4 |
OE |
$21.35 |
$320,250 |
D/D |
15,000 |
155,795 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
Director |
– • – |
2018-03-13 |
4 |
AS |
$149.00 |
$2,235,000 |
D/D |
(15,000) |
140,795 |
0 |
- |
|
86 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
